Navigation Links
Theory of How HIV Attacks is Wrong: Study

A popular theory on how HIV attacks the body's immune system is wrong, a new study has found.

Scientists have long believed that HIV causes the slow depletion of healthy white blood cells -- the T cells which recognize infections so the body can fight them off -- by causing infected T cells to produce virus particles before dying.

This ongoing cycle of infection, HIV production, reinfection and cell destruction has been called the "runaway" hypothesis.

But if this were so, the T cells would be killed off far too quickly, the researchers found.

Using a simple mathematical model, researchers in the United States and Britain showed the "runaway" model would deplete the body's healthy T cells in a matter of months, instead of the years it actually takes.

The results show that a "slow process must be active" in the depletion of the T cells, the authors wrote in the current issue of the journal PLoS Medicine.

Identifying this process "will provide a key insight into the nature of HIV disease and indicate potential new approaches to therapy," they concluded.

A potential explanation for the slow process could be that the virus slowly adapts over the course of the infection, the authors said.

"The virus is constantly mutating and there may be selection - in a Darwinian sense -- over time for 'fitter' mutants of the virus in an infected person," said lead author Andrew Yates of Emory University in Atlanta, Georgia.

"There are several ways the virus could become fitter - for example by being able to infect new cells more readily, or by infected cells producing more new virus, or producing it more rapidly," he said in an e-mail interview.

"The virus adaptation hypothesis requires a lot more experimental investigation, however, and is only a tentative conclusion."


'"/>




Page: 1

Related medicine news :

1. New Information On Virus Goes Against The Age-Old Theory
2. Controversial Theory Says DNA Can Be Pushed To "Dark States"
3. Study Refutes Theory on HIVs Effect on White Blood Cells
4. Maths Theory Shows Genetic Pattern of Tumour Growth
5. Heart Attacks during Menstruation!
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Air Pollution and Heart Attacks
8. Kidney Patients Risk Heart Attacks
9. Kidney Patients Risk Heart Attacks
10. New Medication May Decrease The Frequency Of Angina Attacks
11. Obese Kids Also Prone To Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: